Literature DB >> 13785724

Preliminary observations on the use of streptonigrin as an antitumor agent in human beings.

W L WILSON, C LABRA, E BARRIST.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13785724

Source DB:  PubMed          Journal:  Antibiot Chemother (Northfield)        ISSN： 0570-3123


× No keyword cloud information.
  6 in total

1.  Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.

Authors:  Wen Cai; Mary Hassani; Rajesh Karki; Ervin D Walter; Katherine H Koelsch; Hassan Seradj; Jayana P Lineswala; Hamid Mirzaei; Jeremy S York; Fatemeh Olang; Minoo Sedighi; Jennifer S Lucas; Thomas J Eads; Anthony S Rose; Sahba Charkhzarrin; Nicholas G Hermann; Howard D Beall; Mohammad Behforouz
Journal:  Bioorg Med Chem       Date:  2010-01-25       Impact factor: 3.641

2.  Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.

Authors:  Mohammad Behforouz; Wen Cai; Farahnaz Mohammadi; Mark G Stocksdale; Zhengxiang Gu; Mohammad Ahmadian; Darric E Baty; Michele R Etling; Charmaine H Al-Anzi; Tyson M Swiftney; Lee R Tanzer; Ronald L Merriman; Nancy C Behforouz
Journal:  Bioorg Med Chem       Date:  2006-10-10       Impact factor: 3.641

Review 3.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

4.  A fluopol-ABPP HTS assay to identify PAD inhibitors.

Authors:  Bryan Knuckley; Justin E Jones; Daniel A Bachovchin; Jessica Slack; Corey P Causey; Steven J Brown; Hugh Rosen; Benjamin F Cravatt; Paul R Thompson
Journal:  Chem Commun (Camb)       Date:  2010-08-25       Impact factor: 6.222

5.  Biological assay of streptonigrin (NSC 45383) in body fluids and tissues of mice.

Authors:  R F Pittillo; C Woolley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

6.  A trial of streptonigrin in the treatment of advanced malignant disease.

Authors:  G M Smith; J A Gordon; I A Sewell; H Ellis
Journal:  Br J Cancer       Date:  1967-06       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.